Alma Bio Therapeutics SAS (Alma) and Delphi Genetics SA recently announced that they are taking their strategic alliance...
Singapore – Results from the landmark CANVAS Program showed INVOKANA (canagliflozin) significantly reduc...
Canada based company BioAuxilium specialised in the development of custom TR-FRET assay kit recently announced the succe...
Innovator in influenza vaccines and pandemic preparedness Seqirus recently announced the next major advancement in the u...
Singapore - Zyga Technology, Inc., a US based medical device company announced the issuance of a new US Patent represent...
Singapore- Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells direct...
Scientists have answered the woes of spending hours and hours on sunbeds to achieve the perfect bronzed tone. Better yet...
Researchers have claimed that a drug that lowers blood sugar levels for people with Type 2 diabetes may also significant...
Enzychem Lifesciences, Corp., a Korea based life sciences company announced the initiation of the dose-escalation stage ...
NanoBio Corporation, a US based biopharmaceutical company focused on developing and commercializing vaccines and anti-in...
Singapore - During a symposium, titled "Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Patients with ...
The Scripps Research Institute (TSRI) and ShangPharma Innovation, Inc. (SPII) announced a strategic collaboration to acc...
Singapore - BD (Becton, Dickinson and Company), a global medical technology company, announced 510 (k) clearance from th...
Dr Subir Basak Chief Business Officer, GVK Biosciences Over the last two decades, the Pharmaceutical industry has seen ...
Singapore - Novo Nordisk, a US based global healthcare company announced that the U.S. Food and Drug Administration (FDA...
Singapore: Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving treatments to...
Singapore: Symic Bio, a US based biopharmaceutical company announced the successful completion of a $30 million&nbs...
Singapore: French drug giant Sanofi has inked a $273 million research deal and licence option agreement in metabolic dis...
